1-Piperazinecarboxylic acid, ethyl ester → HCID 13957256, 화합물
반응식
[N:1]1[C:10]2[C:9](=[O:11])[CH:8]=[CH:7][C:6](=[O:12])[C:5]=2[N:4]=[CH:3][CH:2]=1.[CH2:13]([O:15][C:16]([N:18]1[CH2:23][CH2:22][NH:21][CH2:20][CH2:19]1)=[O:17])[CH3:14]>O1CCOCC1>[CH2:13]([O:15][C:16]([N:18]1[CH2:19][CH2:20][N:21]([C:8]2[C:9](=[O:11])[C:10]3[N:1]=[CH:2][CH:3]=[N:4][C:5]=3[C:6](=[O:12])[CH:7]=2)[CH2:22][CH2:23]1)=[O:17])[CH3:14]참가 물질
4
실험 절차
A mixture of 160 mg of 5,8-quinoxalinedione and 316 mg of 1-piperazinecarboxylic acid ethyl ester in 10 ml of dioxane was stirred for 3 hours. The resulting solid was collected, washed with ether and dried, giving 150 mg of the desired product as a red solid, mp 180°-195° C. (dec.).
후처리
- customThe resulting solid was collected
- washwashed with ether
- customdried
출처 및 근거
- ORD 기록
- ord-3de90c4c43e24e7282bc5b9440e6243c
- 출처 데이터셋
- uspto-grants-1987_09
- 특허 번호
- US04692449
반응 노트
불러오는 중…